Clinical Activity of Gemcitabine Plus Pertuzumab in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer - Concepedia

Concepedia

Publication | Closed Access

Clinical Activity of Gemcitabine Plus Pertuzumab in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

180

Citations

18

References

2009

Year

Sharmila Makhija, Lukas C. Amler, D. Glenn, Frederick R. Ueland, Michael A. Gold, Don S. Dizon, Virginia Paton, Chin‐Yu Lin, Thomas Januario, Kimmie Ng,

Journal of Clinical Oncology

Abstract

Pertuzumab may add activity to gemcitabine for the treatment of platinum-resistant ovarian cancer. Low HER3 mRNA expression may predict pertuzumab clinical benefit and be a valuable prognostic marker.

References

	Year	Citations

Page 1